股本结构
单位：万股
| 公告日期 | 2026-07-23 | 2026-03-19 | 2026-03-19 | 2025-07-31 | 2025-03-20 | 2025-03-20 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6253.79 | 6206.29 | 6188.33 | 6116.63 | 6099.09 | 6076.10 |
| 普通股本 | 6253.79 | 6206.29 | 6188.33 | 6116.63 | 6099.09 | 6076.10 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-06-30 | 2026-02-19 | 2025-12-31 | 2025-06-30 | 2025-02-19 | 2024-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：1
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-07-23 | 6253.79 | 未披露 | 定期报告 | 2026-06-30 |
| 2026-03-19 | 6206.29 | 未披露 | 定期报告 | 2026-02-19 |
| 2026-03-19 | 6188.33 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Exercise of stock options
Vesting of RSUs
|
2025-12-31 |
| 2025-07-31 | 6116.63 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-03-20 | 6099.09 | 未披露 | 定期报告 | 2025-02-19 |
| 2025-03-20 | 6076.10 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Exercise of stock options
Vesting of RSUs
|
2024-12-31 |
| 2024-07-25 | 5979.63 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-03-27 | 5938.65 | 未披露 | 定期报告 | 2024-03-27 |
| 2024-03-21 | 5930.22 | 未披露 | 定期报告 | 2024-02-20 |
| 2024-03-21 | 5919.45 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issue of share capital
Exercise of stock options
|
2023-12-31 |
| 2023-11-21 | 5907.85 | 未披露 | 定期报告 | 2023-11-21 |
| 2023-07-20 | 5820.04 | 未披露 |
更多>>
Ordinary shares offered 2,244,899 shares by the company
|
2023-07-24 |
| 2023-07-27 | 5595.55 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-07-17 | 5567.81 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-16 | 5557.05 | 未披露 | 定期报告 | 2023-02-15 |
| 2023-01-30 | 5544.77 | 未披露 | 定期报告 | 2023-01-30 |
| 2023-03-16 | 5539.59 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issue of share capital
Exercise of stock options
|
2022-12-31 |
| 2022-07-28 | 5506.15 | 未披露 |
更多>>
From December 31, 2021 to June 30, 2022
Exercise of options
Vesting of RSUs
Global public offering on Euronext and Nasdaq on March 23, 2022
Over-allotment option exercised by underwriters on March 29, 2022
|
2022-06-30 |
| 2022-03-28 | 5400.16 | 未披露 |
更多>>
1.Global offering 2,333,334 ordinary shares offered.
2.Except as otherwise noted, the number of ordinary shares that will be outstanding after this global offering is based on 51,668,315 ordinary shares outstanding as of December 31, 2021.
|
2022-03-28 |
| 2022-03-21 | 5190.53 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-03-21 | 5166.83 | 未披露 |
更多>>
from December 31, 2020 to December 31, 2021
Issue of new shares
Exercise of stock options
|
2021-12-31 |
| 2021-07-29 | 5139.87 | 未披露 |
更多>>
From December 31, 2020 to June 30, 2021
Exercise of options
Global public offering on Euronext and Nasdaq on February 2, 2021
Over-allotment option exercised by underwriters on February 4, 2021
|
2021-06-30 |
| 2021-03-30 | 5130.56 | 未披露 | 定期报告 | 2021-03-16 |
| 2021-02-05 | 5023.35 | 未披露 |
更多>>
1.Global offering 3,125,000 ordinary shares offered by the company.
2.Except as otherwise noted, the number of ordinary shares that will be outstanding after this global offering is based on 47,108,499 ordinary shares outstanding as of June 30, 2020.
|
2021-02-05 |
| 2021-03-30 | 4757.13 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issue of new shares
Exercise of stock options
|
2020-12-31 |
| 2020-07-30 | 4710.85 | 未披露 |
更多>>
From December 31, 2019 to June 30, 2020
Exercise of options
Global public offering on Euronext and Nasdaq on May 28, 2020
Over-allotment option exercised by underwriters on May 29, 2020
|
2020-06-30 |
| 2020-06-01 | 4645.10 | 未披露 |
更多>>
1.Global offering 3,658,515 ordinary shares offered by us
2.Except as otherwise noted, the number of ordinary shares that will be outstanding after this global offering is based on 42,792,476 ordinary shares outstanding as of March 31, 2020
|
2020-06-01 |
| 2020-05-26 | 4279.25 | 未披露 | 定期报告 | 2020-03-31 |
| 2020-03-31 | 4279.11 | 未披露 | 定期报告 | 2020-03-16 |
| 2020-03-31 | 4276.15 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issue of new shares
Exercise of stock options
|
2019-12-31 |
| 2019-11-12 | 4212.20 | 未披露 | 定期报告 | 2019-11-12 |
| 2019-11-06 | 3812.20 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Exercise of options in July 2019
Exercise of options in August 2019
Exercise of options in September 2019
|
2019-09-30 |
| 2019-08-01 | 3810.75 | 未披露 |
更多>>
from December 31, 2018 to June 30, 2019
Exercise of options in January 2019
Share subscription from Johnson & Johnson Innovation Inc.
Exercise of options in February 2019
Exercise of options in March 2019
Exercise of options in April 2019
Exercise of options in May 2019
Exercise of options in June 2019
|
2019-06-30 |
| 2019-05-08 | 3761.61 | 未披露 | 定期报告 | 2019-04-09 |
| 2019-03-26 | 3797.25 | 未披露 | 定期报告 | 2019-03-26 |
| 2019-03-26 | 3799.18 | 未披露 | 定期报告 | 2019-03-22 |
| 2019-03-26 | 3597.53 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Exercise of options in January 2018
Exercise of options in March 2018
Exercise of options in April 2018
Exercise of options in May 2018
Exercise of options in June 2018
Exercise of options in July 2018
Exercise of options in August 2018
Exercise of options in September 2018
U.S. third public offering on Nasdaq on September 18, 2018
Exercise of options in October 2018
Exercise of options in November 2018
Exercise of options in December 2018
|
2018-12-31 |
| 2018-08-02 | 3245.08 | 未披露 |
更多>>
from December 31, 2017 to June 30, 2018
Exercise of Options in January 2018
Exercise of Options in March 2018
Exercise of Options in April 2018
Exercise of Options in May 2018
Exercise of Options in June 2018
|
2018-06-30 |
| 2018-03-26 | 3240.31 | 未披露 | 定期报告 | 2018-03-16 |
| 2018-03-26 | 3218.06 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
U.S. initial public offering on Nasdaq on May 17, 2017
Over-allotment option exercised by underwriters on May 19, 2017
Exercise of Options on August 24, 2017
Exercise of Options on September 1, 2017
Exercise of Options on October 2, 2017
Exercise of Options on November 7, 2017
Exercise of Options on November 14, 2017
Exercise of Options on November 15, 2017
Exercise of Options on November 21, 2017
Exercise of Options on November 22, 2017
Exercise of Options on December 4, 2017
U.S. second public offering on Nasdaq on December 13, 2017
Over-allotment option exercised by underwriters on December 14, 2017
Exercise of Options on December 18, 2017
|
2017-12-31 |
| 2017-08-24 | 2687.12 | 未披露 |
更多>>
from December 31, 2016 to June 30, 2017
U.S. initial public offering on Nasdaq on May 17, 2017
Over-allotment option exercised by underwriters on May 19, 2017
|
2017-06-30 |
| 2017-05-19 | 2599.15 | 未披露 |
更多>>
1.ADSs offered by us 5,865,000 ADSs
2.The number of our ordinary shares to be outstanding after this offering is based on 20,126,479 ordinary shares outstanding as of December 31, 2016
|
2017-05-18 |
| 2017-05-16 | 2012.65 | 未披露 | 定期报告 | 2016-12-31 |
From December 31, 2024 to December 31, 2025
Exercise of stock options
Vesting of RSUs
From December 31, 2023 to December 31, 2024
Exercise of stock options
Vesting of RSUs
From December 31,2022 to December 31,2023
Issue of share capital
Exercise of stock options
Ordinary shares offered 2,244,899 shares by the company
From December 31, 2021 to December 31, 2022
Issue of share capital
Exercise of stock options
From December 31, 2021 to June 30, 2022
Exercise of options
Vesting of RSUs
Global public offering on Euronext and Nasdaq on March 23, 2022
Over-allotment option exercised by underwriters on March 29, 2022
1.Global offering 2,333,334 ordinary shares offered.
2.Except as otherwise noted, the number of ordinary shares that will be outstanding after this global offering is based on 51,668,315 ordinary shares outstanding as of December 31, 2021.
from December 31, 2020 to December 31, 2021
Issue of new shares
Exercise of stock options
From December 31, 2020 to June 30, 2021
Exercise of options
Global public offering on Euronext and Nasdaq on February 2, 2021
Over-allotment option exercised by underwriters on February 4, 2021
1.Global offering 3,125,000 ordinary shares offered by the company.
2.Except as otherwise noted, the number of ordinary shares that will be outstanding after this global offering is based on 47,108,499 ordinary shares outstanding as of June 30, 2020.
from December 31, 2019 to December 31, 2020
Issue of new shares
Exercise of stock options
From December 31, 2019 to June 30, 2020
Exercise of options
Global public offering on Euronext and Nasdaq on May 28, 2020
Over-allotment option exercised by underwriters on May 29, 2020
1.Global offering 3,658,515 ordinary shares offered by us
2.Except as otherwise noted, the number of ordinary shares that will be outstanding after this global offering is based on 42,792,476 ordinary shares outstanding as of March 31, 2020
From December 31, 2018 to December 31, 2019
Issue of new shares
Exercise of stock options
from June 30, 2019 to September 30, 2019
Exercise of options in July 2019
Exercise of options in August 2019
Exercise of options in September 2019
from December 31, 2018 to June 30, 2019
Exercise of options in January 2019
Share subscription from Johnson & Johnson Innovation Inc.
Exercise of options in February 2019
Exercise of options in March 2019
Exercise of options in April 2019
Exercise of options in May 2019
Exercise of options in June 2019
from December 31, 2017 to December 31, 2018
Exercise of options in January 2018
Exercise of options in March 2018
Exercise of options in April 2018
Exercise of options in May 2018
Exercise of options in June 2018
Exercise of options in July 2018
Exercise of options in August 2018
Exercise of options in September 2018
U.S. third public offering on Nasdaq on September 18, 2018
Exercise of options in October 2018
Exercise of options in November 2018
Exercise of options in December 2018
from December 31, 2017 to June 30, 2018
Exercise of Options in January 2018
Exercise of Options in March 2018
Exercise of Options in April 2018
Exercise of Options in May 2018
Exercise of Options in June 2018
from December 31, 2016 to December 31, 2017
U.S. initial public offering on Nasdaq on May 17, 2017
Over-allotment option exercised by underwriters on May 19, 2017
Exercise of Options on August 24, 2017
Exercise of Options on September 1, 2017
Exercise of Options on October 2, 2017
Exercise of Options on November 7, 2017
Exercise of Options on November 14, 2017
Exercise of Options on November 15, 2017
Exercise of Options on November 21, 2017
Exercise of Options on November 22, 2017
Exercise of Options on December 4, 2017
U.S. second public offering on Nasdaq on December 13, 2017
Over-allotment option exercised by underwriters on December 14, 2017
Exercise of Options on December 18, 2017
from December 31, 2016 to June 30, 2017
U.S. initial public offering on Nasdaq on May 17, 2017
Over-allotment option exercised by underwriters on May 19, 2017
1.ADSs offered by us 5,865,000 ADSs
2.The number of our ordinary shares to be outstanding after this offering is based on 20,126,479 ordinary shares outstanding as of December 31, 2016